Developing an Accurate Price Model for Personalized Medicines

Randy Vogenberg, PhD, RPh

Video Categories: Pricing

Randy Vogenberg discusses the complexities of developing pricing for personalized medicine products
October 1, 2018

How International Standards for Molecular Biomarker Testing in Lung Cancer Have Influenced Which Tests are Routinely Performed

Drs. Roy Herbst and David Rimm discuss the 50-gene panel that has become an ISLC-mandated standard for all patients with lung cancer; however, the components of cancer biomarker testing panels must be fluid and respond to new developments in the field as reported in the literature and/or at international cancer [ Read More ]

November 24, 2014

Foundation Medicine on a Molecular Level

Dr. Gary Palmer explains how Foundation Medicine is working to improve cancer therapies and personalized medicine on a molecular level.